BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 33396535)

  • 1. Exosomal miRNAs as Potential Biomarkers to Monitor Phosphodiesterase 5 Inhibitor Induced Anti-Fibrotic Effects on CCl
    Broermann A; Schmid R; Gabrielyan O; Sakowski M; Eisele C; Keller S; Wolff M; Baum P; Stierstorfer B; Huber J; Krämer BK; Hocher B; Streicher R; Delić D
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linagliptin and telmisartan induced effects on renal and urinary exosomal miRNA expression in rats with 5/6 nephrectomy.
    Delić D; Wiech F; Urquhart R; Gabrielyan O; Rieber K; Rolser M; Tsuprykov O; Hasan AA; Krämer BK; Baum P; Köhler A; Gantner F; Mark M; Hocher B; Klein T
    Sci Rep; 2020 Feb; 10(1):3373. PubMed ID: 32099009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomes derived from miR-181-5p-modified adipose-derived mesenchymal stem cells prevent liver fibrosis via autophagy activation.
    Qu Y; Zhang Q; Cai X; Li F; Ma Z; Xu M; Lu L
    J Cell Mol Med; 2017 Oct; 21(10):2491-2502. PubMed ID: 28382720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of miR-199a-5p, miR-214-3p and miR-99b-5p as Fibrosis-Specific Extracellular Biomarkers and Promoters of HSC Activation.
    Messner CJ; Schmidt S; Özkul D; Gaiser C; Terracciano L; Krähenbühl S; Suter-Dick L
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin reorganizes miRNA expression in a mouse model of liver fibrosis.
    Hassan ZK; Al-Olayan EM
    Asian Pac J Cancer Prev; 2012; 13(11):5405-8. PubMed ID: 23317191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small RNA Sequencing Reveals Exosomal miRNAs Involved in the Treatment of Asthma by Scorpio and Centipede.
    Tang B; Wu Y; Fang H; Wu Y; Shi K
    Biomed Res Int; 2020; 2020():1061407. PubMed ID: 32016112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients.
    Delić D; Eisele C; Schmid R; Baum P; Wiech F; Gerl M; Zimdahl H; Pullen SS; Urquhart R
    PLoS One; 2016; 11(3):e0150154. PubMed ID: 26930277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
    Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
    J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic Delivery of scAAV8-Encoded MiR-29a Ameliorates Hepatic Fibrosis in Carbon Tetrachloride-Treated Mice.
    Knabel MK; Ramachandran K; Karhadkar S; Hwang HW; Creamer TJ; Chivukula RR; Sheikh F; Clark KR; Torbenson M; Montgomery RA; Cameron AM; Mendell JT; Warren DS
    PLoS One; 2015; 10(4):e0124411. PubMed ID: 25923107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomal miR-103-3p from LPS-activated THP-1 macrophage contributes to the activation of hepatic stellate cells.
    Chen L; Yao X; Yao H; Ji Q; Ding G; Liu X
    FASEB J; 2020 Apr; 34(4):5178-5192. PubMed ID: 32061112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression.
    Hyun J; Wang S; Kim J; Rao KM; Park SY; Chung I; Ha CS; Kim SW; Yun YH; Jung Y
    Nat Commun; 2016 Mar; 7():10993. PubMed ID: 27001906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impact of serum exosomal microRNA in liver fibrosis.
    Chang Y; Han JA; Kang SM; Jeong SW; Ryu T; Park HS; Yoo JJ; Lee SH; Kim SG; Kim YS; Kim HS; Jin SY; Ryu S; Jang JY
    PLoS One; 2021; 16(9):e0255672. PubMed ID: 34506494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated miR-129-5p attenuates hepatic fibrosis through the NF-κB signaling pathway via PEG3 in a carbon CCl
    Zhu Y; Hu Y; Cheng X; Li Q; Niu Q
    J Mol Histol; 2021 Jun; 52(3):491-501. PubMed ID: 33743102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential biomarkers in NASH-induced liver cirrhosis with hepatocellular carcinoma: A preliminary work on roles of exosomal miR-182, miR-301a, and miR-373.
    Muhammad Yusuf AN; Raja Ali RA; Muhammad Nawawi KN; Mokhtar NM
    Malays J Pathol; 2020 Dec; 42(3):377-384. PubMed ID: 33361718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using Next-generation Sequencing to Identify Novel Exosomal miRNAs as Biomarkers for Significant Hepatic Fibrosis.
    Wang Q; Hu Q; Ying Y; Lu C; Li W; Huang C; Xu W; Li Q; Qi X; Zhang X; Liu X; Du Z; Feng Y; Zhang Y; Li X; Ji Y; Zhang J; Wang J; Chen L; Huang Y
    Discov Med; 2021; 31(164):147-159. PubMed ID: 35188889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-17-5p-activated Wnt/β-catenin pathway contributes to the progression of liver fibrosis.
    Yu F; Lu Z; Huang K; Wang X; Xu Z; Chen B; Dong P; Zheng J
    Oncotarget; 2016 Jan; 7(1):81-93. PubMed ID: 26637809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep sequencing analysis of microRNA expression in porcine serum-induced hepatic fibrosis rats.
    Ge S; Wang X; Xie J; Yi X; Liu F
    Ann Hepatol; 2014; 13(4):439-49. PubMed ID: 24927615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers.
    Lugli G; Cohen AM; Bennett DA; Shah RC; Fields CJ; Hernandez AG; Smalheiser NR
    PLoS One; 2015; 10(10):e0139233. PubMed ID: 26426747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated expression profiles of mRNA and miRNA in a gerbil model of fatty liver fibrosis treated with exenatide.
    Liu Y; Wu H; Wang Z; Wu J; Ying S; Huang M; Li Y
    Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101312. PubMed ID: 33592427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
    Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
    BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.